#century-therapeutics
Latest news and interesting information about century-therapeutics.
Mizuho Starts Century Therapeutics at Outperform
Mizuho initiated coverage on Century Therapeutics with an Outperform rating and $8.00 target, highlighting cell therapy for Type 1 Diabetes.
...
